{ "meta": { "disclaimer": "Do not rely on openFDA to make decisions regarding medical care. While we make every effort to ensure that data is accurate, you should assume all results are unvalidated. We may limit or otherwise restrict your access to the API in line with our Terms of Service.", "terms": "https://open.fda.gov/terms/", "license": "https://open.fda.gov/license/", "last_updated": "2026-07-30", "results": { "skip": 0, "limit": 1, "total": 1 } }, "results": [ { "safetyreportversion": "1", "safetyreportid": "14422580", "primarysourcecountry": "US", "occurcountry": "US", "transmissiondateformat": "102", "transmissiondate": "20180509", "reporttype": "1", "serious": "2", "receivedateformat": "102", "receivedate": "20180123", "receiptdateformat": "102", "receiptdate": "20180123", "fulfillexpeditecriteria": "2", "companynumb": "US-INSYS THERAPEUTICS, INC-INS201710-000636", "duplicate": "1", "reportduplicate": { "duplicatesource": "INSYS", "duplicatenumb": "US-INSYS THERAPEUTICS, INC-INS201710-000636" }, "primarysource": { "reportercountry": "US", "qualification": "3" }, "sender": { "sendertype": "2", "senderorganization": "FDA-Public Use" }, "receiver": { "receivertype": "6", "receiverorganization": "FDA" }, "patient": { "patientweight": "60.8", "patientsex": "1", "reaction": [ { "reactionmeddraversionpt": "21.0", "reactionmeddrapt": "Somnolence", "reactionoutcome": "1" } ], "drug": [ { "drugcharacterization": "2", "medicinalproduct": "VASCEPA", "drugstructuredosagenumb": "1", "drugstructuredosageunit": "002", "activesubstance": { "activesubstancename": "ICOSAPENT ETHYL" }, "openfda": { "application_number": [ "NDA202057" ], "brand_name": [ "VASCEPA" ], "generic_name": [ "ICOSAPENT ETHYL" ], "manufacturer_name": [ "Amarin Pharma Inc." ], "product_ndc": [ "52937-001", "52937-101", "52937-003", "52937-005" ], "product_type": [ "HUMAN PRESCRIPTION DRUG" ], "route": [ "ORAL" ], "substance_name": [ "ICOSAPENT ETHYL" ], "rxcui": [ "1304979", "1304985", "1811180", "1811182" ], "spl_id": [ "86b35fe3-d1cf-478e-849b-2ea0c87bda33" ], "spl_set_id": [ "9c1a2828-1583-4414-ab22-a60480e8e508" ], "package_ndc": [ "52937-001-04", "52937-001-20", "52937-001-21", "52937-101-08", "52937-003-40", "52937-003-16", "52937-005-20" ], "unii": [ "6GC8A4PAYH" ] } }, { "drugcharacterization": "1", "medicinalproduct": "SYNDROS", "drugbatchnumb": "160697", "drugauthorizationnumb": "205525", "drugstructuredosagenumb": "4.2", "drugstructuredosageunit": "003", "drugadministrationroute": "048", "drugindication": "PRODUCT USED FOR UNKNOWN INDICATION", "actiondrug": "5", "drugadditional": "3", "activesubstance": { "activesubstancename": "DRONABINOL" }, "openfda": { "application_number": [ "NDA205525" ], "brand_name": [ "SYNDROS" ], "generic_name": [ "DRONABINOL" ], "manufacturer_name": [ "Wellhouse Pharma, LLC", "Benuvia Operations, LLC" ], "product_ndc": [ "85776-201", "78613-201" ], "product_type": [ "HUMAN PRESCRIPTION DRUG" ], "route": [ "ORAL" ], "substance_name": [ "DRONABINOL" ], "rxcui": [ "1928948", "1928954" ], "spl_id": [ "dcc02ae3-f1fa-431e-81bb-c52d35b81c66", "3e1cbbb1-291c-41bb-b209-93c1fb08313a" ], "spl_set_id": [ "3cdcb4f5-5af9-4ff7-b535-2a5cf4c6da89", "a7801c70-995d-46a2-91ee-141ef427c6b5" ], "package_ndc": [ "85776-201-30", "78613-201-30" ], "nui": [ "N0000175782", "M0003267" ], "pharm_class_epc": [ "Cannabinoid [EPC]" ], "pharm_class_cs": [ "Cannabinoids [CS]" ], "unii": [ "7J8897W37S" ] } }, { "drugcharacterization": "2", "medicinalproduct": "LOSARTAN.", "drugstructuredosagenumb": "25", "drugstructuredosageunit": "003", "activesubstance": { "activesubstancename": "LOSARTAN" }, "openfda": { "application_number": [ "ANDA215959" ], "brand_name": [ "LOSARTAN POTASSIUM" ], "generic_name": [ "LOSARTAN" ], "manufacturer_name": [ "Granules Pharmaceuticals Inc.", "Granules India Ltd" ], "product_ndc": [ "70010-741", "70010-742", "70010-743", "62207-741", "62207-742", "62207-743" ], "product_type": [ "HUMAN PRESCRIPTION DRUG" ], "route": [ "ORAL" ], "substance_name": [ "LOSARTAN POTASSIUM" ], "rxcui": [ "979480", "979485", "979492" ], "spl_id": [ "451da3de-077d-522d-e063-6394a90a3537", "39e0a359-f9d7-c3fb-e063-6394a90a86a8" ], "spl_set_id": [ "ca012edc-923d-4ada-a261-db82b71b3c4f", "f9953f51-f30a-952d-e053-6394a90abf5f" ], "package_ndc": [ "70010-741-03", "70010-741-09", "70010-741-10", "70010-742-03", "70010-742-09", "70010-742-10", "70010-743-03", "70010-743-09", "70010-743-10", "62207-741-54", "62207-741-49", "62207-742-54", "62207-742-49", "62207-743-54", "62207-743-49" ], "unii": [ "3ST302B24A" ] } }, { "drugcharacterization": "2", "medicinalproduct": "PEPCID", "drugstructuredosagenumb": "20", "drugstructuredosageunit": "003", "activesubstance": { "activesubstancename": "FAMOTIDINE" }, "openfda": { "application_number": [ "ANDA075805" ], "brand_name": [ "PEPCID" ], "generic_name": [ "FAMOTIDINE" ], "manufacturer_name": [ "Bausch Health US LLC" ], "product_ndc": [ "0187-4420", "0187-4440" ], "product_type": [ "HUMAN PRESCRIPTION DRUG" ], "route": [ "ORAL" ], "substance_name": [ "FAMOTIDINE" ], "rxcui": [ "104094", "104095", "284245", "310273" ], "spl_id": [ "7d2d8240-b53a-4395-bd8d-d326522d5865" ], "spl_set_id": [ "a06502d9-7903-4f37-833e-e5763d502def" ], "package_ndc": [ "0187-4420-30", "0187-4420-10", "0187-4440-30", "0187-4440-10" ], "nui": [ "N0000000151", "N0000175784" ], "pharm_class_moa": [ "Histamine H2 Receptor Antagonists [MoA]" ], "pharm_class_epc": [ "Histamine-2 Receptor Antagonist [EPC]" ], "unii": [ "5QZO15J2Z8" ] } }, { "drugcharacterization": "2", "medicinalproduct": "FOLIC ACID.", "activesubstance": { "activesubstancename": "FOLIC ACID" }, "openfda": { "brand_name": [ "VENTRIXYL", "FOLIC ACID", "QUIOFIC", "VENEXA", "VITRAMYN", "MULTITAM", "VITREXYL", "VITREXATE", "VITRANOL" ], "generic_name": [ "FOLIC ACID" ], "manufacturer_name": [ "PureTek Corporation", "Leading Pharma, LLC", "Amneal Pharmaceuticals of New York LLC", "Solubiomix, LLC", "Cadila Pharmaceuticals Limited", "Ayurax, LLC", "SUNRISE PHARMACEUTICAL, INC.", "Modavar Pharmaceuticals LLC", "Method Pharmaceuticals, LLC", "XGen Pharmaceuticals DJB, Inc.", "QUAGEN PHARMACEUTICALS LLC", "Rising Pharma Holdings, Inc.", "Amneal Pharmaceuticals LLC", "Fresenius Kabi USA, LLC", "Chartwell RX, LLC." ], "product_ndc": [ "59088-186", "69315-127", "53746-361", "69499-501", "59088-176", "71209-007", "73308-501", "11534-165", "72241-050", "58657-151", "59088-193", "39822-1100", "70752-231", "16571-881", "65162-361", "59088-525", "59088-164", "59088-167", "59088-171", "63323-184", "62135-210" ], "product_type": [ "HUMAN PRESCRIPTION DRUG" ], "route": [ "ORAL", "INTRAMUSCULAR", "INTRAVENOUS", "SUBCUTANEOUS" ], "substance_name": [ "CHOLECALCIFEROL", "RIBOFLAVIN", "NIACINAMIDE", "ASCORBIC ACID", "FOLIC ACID", "CYANOCOBALAMIN", "CALCIUM CARBONATE", "SELENIUM", "VITAMIN A ACETATE", "THIAMINE MONONITRATE", "ZINC OXIDE", "MANGANESE SULFATE", ".ALPHA.-TOCOPHEROL ACETATE, DL-", "MAGNESIUM OXIDE", "CHROMIUM NICOTINATE", "PYRIDOXINE HYDROCHLORIDE", "MOLYBDENUM" ], "spl_id": [ "286669b9-5e8e-a446-e063-6394a90a2287", "92322e52-3179-4738-8c8a-14fef62311d4", "299a16c1-9627-45e2-a30c-e0f07ae9399a", "c0176981-bd6e-480f-9167-80555050b025", "f204b6b0-92af-3c22-e053-2995a90ad0aa", "fdcdd5ea-a352-4b01-a972-2ed5a82e3a61", "f6a753c1-e141-42a5-b758-7faad81c9427", "5250e701-9f7a-42a8-bae9-95c4779f06aa", "f1dbb47b-a3bd-472b-b565-053e5db411eb", "41b4d71d-2dc2-36bd-e063-6294a90af1e1", "548ee394-41b9-d346-e063-6394a90a0773", "48eb23cf-7425-a5cc-e063-6294a90a5021", "067af2c9-3769-40d4-a991-217390ece384", "a5219f26-2238-4666-9aae-9c98b3003079", "e5ed5369-340d-40ad-b863-c02fd63d5911", "4f5f0e70-672d-571b-e063-6394a90ad1da", "f2048b24-433c-98ba-e053-2995a90a5e85", "f204b4b3-176f-8839-e053-2a95a90a7115", "2445290b-6803-4364-ab42-65e6c550fdcd", "2589605c-12b7-ed10-e063-6294a90ab52b" ], "spl_set_id": [ "c29dc729-93be-2a20-e053-2a95a90a8ca3", "1ba8c407-9613-4319-ac40-0a429cb0f3f4", "fd85395e-6a0b-4072-a80b-36095c0c6dd6", "b868b314-591d-458b-be82-2bcd0b73cce1", "ba130779-cdfd-086d-e053-2a95a90a2590", "103c2cdd-5822-48ba-b62a-e2b11aa444ef", "96618bf8-6c03-4df3-9896-b7ef27ca392a", "6854412b-7ecb-4107-85eb-730f14e23f06", "0eea15e4-7e5d-44e9-818b-a0bdf5271c78", "b9c315ff-cecb-8b75-e053-2995a90aa204", "c8af7616-5178-6df0-e053-2a95a90a334d", "c5b2b84d-9f5e-4b81-ba10-9f2854e5dce9", "354366ea-3702-4706-9fc0-0244b7278bd8", "0baa10dd-6d1d-4946-8236-566451132da3", "c8fe09f0-b32b-43e3-8de7-ed38593b33b4", "cee15842-4a9e-c6ba-e053-2a95a90aebc5", "ae064a9e-daba-fa86-e053-2a95a90a16a7", "b34fee43-bea9-45b7-e053-2a95a90aad4d", "e215318c-4f8b-4711-ae76-f370d1da0f3b", "9a533666-8906-438e-adf7-11bb162ecb63" ], "package_ndc": [ "59088-186-54", "69315-127-01", "69315-127-10", "53746-361-01", "53746-361-10", "69499-501-75", "59088-176-54", "71209-007-05", "71209-007-11", "73308-501-75", "11534-165-01", "11534-165-03", "11534-165-90", "72241-050-05", "72241-050-11", "58657-151-10", "58657-151-01", "59088-193-54", "39822-1100-1", "70752-231-10", "70752-231-11", "16571-881-10", "16571-881-01", "65162-361-01", "65162-361-10", "65162-361-50", "65162-361-11", "59088-525-54", "59088-164-54", "59088-171-54", "59088-167-54", "63323-184-10", "62135-210-90", "62135-210-01", "62135-210-05", "62135-210-10", "62135-210-72", "62135-210-97" ], "nui": [ "M0022797", "N0000175952", "N0000193618", "M0001797", "M0022794", "N0000175951" ], "pharm_class_cs": [ "Vitamin D [CS]", "Ascorbic Acid [CS]", "Vitamin B 12 [CS]" ], "pharm_class_epc": [ "Vitamin D [EPC]", "Vitamin C [EPC]", "Vitamin B12 [EPC]" ], "unii": [ "1C6V77QF41", "TLM2976OFR", "25X51I8RD4", "PQ6CK8PD0R", "935E97BOY8", "P6YC3EG204", "H0G9379FGK", "H6241UJ22B", "3LE3D9D6OY", "8K0I04919X", "SOI2LOH54Z", "W00LYS4T26", "WR1WPI7EW8", "3A3U0GI71G", "A150AY412V", "68Y4CF58BV", "81AH48963U" ], "application_number": [ "ANDA040796", "ANDA040625", "NDA216395", "ANDA202437", "ANDA204418", "ANDA211064", "ANDA202522", "ANDA091145", "ANDA089202", "ANDA090035" ], "rxcui": [ "310410", "2707361", "2733998", "237786" ] } }, { "drugcharacterization": "2", "medicinalproduct": "TRICOR", "drugstructuredosagenumb": "145", "drugstructuredosageunit": "003", "activesubstance": { "activesubstancename": "FENOFIBRATE" }, "openfda": {} }, { "drugcharacterization": "2", "medicinalproduct": "ACTOS", "drugstructuredosagenumb": "30", "drugstructuredosageunit": "003", "activesubstance": { "activesubstancename": "PIOGLITAZONE HYDROCHLORIDE" }, "openfda": { "application_number": [ "NDA021073" ], "brand_name": [ "ACTOS" ], "generic_name": [ "PIOGLITAZONE" ], "manufacturer_name": [ "Takeda Pharmaceuticals America, Inc." ], "product_ndc": [ "64764-151", "64764-301", "64764-451" ], "product_type": [ "HUMAN PRESCRIPTION DRUG" ], "route": [ "ORAL" ], "substance_name": [ "PIOGLITAZONE HYDROCHLORIDE" ], "rxcui": [ "261266", "261267", "261268", "312440", "312441", "317573" ], "spl_id": [ "20e43dff-4bf2-4ae7-82a1-e7e895123f93" ], "spl_set_id": [ "d2ddc491-88a9-4063-9150-443b4fa4330c" ], "package_ndc": [ "64764-151-04", "64764-151-05", "64764-151-06", "64764-151-02", "64764-301-14", "64764-301-15", "64764-301-16", "64764-301-02", "64764-451-24", "64764-451-25", "64764-451-26", "64764-451-02" ], "unii": [ "JQT35NPK6C" ] } }, { "drugcharacterization": "2", "medicinalproduct": "VITAMIN D3", "drugstructuredosagenumb": "2000", "drugstructuredosageunit": "025", "activesubstance": { "activesubstancename": "CHOLECALCIFEROL" }, "openfda": { "application_number": [ "ANDA090455" ], "brand_name": [ "VITAMIN D" ], "generic_name": [ "ERGOCALCIFEROL" ], "manufacturer_name": [ "Strides Pharma Science Limited" ], "product_ndc": [ "64380-737" ], "product_type": [ "HUMAN PRESCRIPTION DRUG" ], "route": [ "ORAL" ], "substance_name": [ "ERGOCALCIFEROL" ], "rxcui": [ "1367410" ], "spl_id": [ "1cc589f7-cd6d-40a6-8fce-c965e8945eae" ], "spl_set_id": [ "2c4c0a36-12cf-444d-9d57-de983eef4d36" ], "package_ndc": [ "64380-737-06", "64380-737-25" ], "nui": [ "M0007651", "N0000175909" ], "pharm_class_cs": [ "Ergocalciferols [CS]" ], "pharm_class_epc": [ "Provitamin D2 Compound [EPC]" ], "unii": [ "VS041H42XC" ] } }, { "drugcharacterization": "2", "medicinalproduct": "LIVALO", "drugstructuredosagenumb": "4", "drugstructuredosageunit": "003", "activesubstance": { "activesubstancename": "PITAVASTATIN CALCIUM" }, "openfda": { "application_number": [ "NDA022363" ], "brand_name": [ "LIVALO" ], "generic_name": [ "PITAVASTATIN CALCIUM" ], "manufacturer_name": [ "Kowa Pharmaceuticals America, Inc." ], "product_ndc": [ "66869-104", "66869-204", "66869-404" ], "product_type": [ "HUMAN PRESCRIPTION DRUG" ], "route": [ "ORAL" ], "substance_name": [ "PITAVASTATIN CALCIUM" ], "rxcui": [ "861643", "861646", "861648", "861650", "861652", "861654" ], "spl_id": [ "aacce141-185f-4d20-adb1-6cca3a9c87c4" ], "spl_set_id": [ "44dcbf97-99ec-427c-ba50-207e0069d6d2" ], "package_ndc": [ "66869-104-90", "66869-204-90", "66869-204-07", "66869-404-90", "66869-404-07" ], "unii": [ "IYD54XEG3W" ] } }, { "drugcharacterization": "2", "medicinalproduct": "NEURONTIN", "drugstructuredosagenumb": "300", "drugstructuredosageunit": "003", "activesubstance": { "activesubstancename": "GABAPENTIN" }, "openfda": { "application_number": [ "NDA020235", "NDA021129", "NDA020882" ], "brand_name": [ "NEURONTIN" ], "generic_name": [ "GABAPENTIN" ], "manufacturer_name": [ "Parke-Davis Div of Pfizer Inc", "Viatris Specialty LLC" ], "product_ndc": [ "0071-0805", "0071-0803", "0071-0806", "0071-0513", "0071-0401", "0071-2012", "58151-281", "58151-282", "58151-283", "58151-284", "58151-285", "58151-290" ], "product_type": [ "HUMAN PRESCRIPTION DRUG" ], "route": [ "ORAL" ], "substance_name": [ "GABAPENTIN" ], "rxcui": [ "105028", "105029", "105030", "261280", "261281", "283523", "310430", "310431", "310432", "310433", "310434", "351973" ], "spl_id": [ "e730d5df-d47b-4d7f-ae3b-bd449f6b1213", "2d43f32d-2d96-4011-84ac-507c3307dc27" ], "spl_set_id": [ "ee9ad9ed-6d9f-4ee1-9d7f-cfad438df388", "97935fd9-1d4a-43b6-a5d9-de994591187b" ], "package_ndc": [ "0071-0803-24", "0071-0803-40", "0071-0805-24", "0071-0805-40", "0071-0806-24", "0071-0806-40", "0071-0513-24", "0071-0401-24", "0071-2012-23", "0071-2012-44", "0071-2012-47", "58151-281-01", "58151-282-01", "58151-283-01", "58151-284-01", "58151-285-01", "58151-290-35" ], "nui": [ "N0000008486" ], "pharm_class_pe": [ "Decreased Central Nervous System Disorganized Electrical Activity [PE]" ], "unii": [ "6CW7F3G59X" ] } }, { "drugcharacterization": "2", "medicinalproduct": "GENVOYA", "drugadministrationroute": "048", "activesubstance": { "activesubstancename": "COBICISTAT\\ELVITEGRAVIR\\EMTRICITABINE\\TENOFOVIR ALAFENAMIDE FUMARATE" }, "openfda": { "application_number": [ "NDA207561" ], "brand_name": [ "GENVOYA" ], "generic_name": [ "ELVITEGRAVIR, COBICISTAT, EMTRICITABINE, AND TENOFOVIR ALAFENAMIDE" ], "manufacturer_name": [ "Gilead Sciences, Inc." ], "product_ndc": [ "61958-1901" ], "product_type": [ "HUMAN PRESCRIPTION DRUG" ], "route": [ "ORAL" ], "substance_name": [ "ELVITEGRAVIR", "COBICISTAT", "EMTRICITABINE", "TENOFOVIR ALAFENAMIDE FUMARATE" ], "rxcui": [ "1721613", "1721619" ], "spl_id": [ "7bb9d232-d878-47d0-8262-abc4d06b37f7" ], "spl_set_id": [ "34784acf-15ed-4715-b504-eb30430518e9" ], "package_ndc": [ "61958-1901-1" ], "nui": [ "N0000000127", "N0000175887", "N0000185507", "N0000190114", "N0000191001", "N0000185503", "N0000182137", "N0000190107", "N0000190108", "N0000190113", "N0000191423", "N0000175462", "M0015066", "N0000009947" ], "pharm_class_moa": [ "HIV Integrase Inhibitors [MoA]", "Cytochrome P450 2C9 Inducers [MoA]", "Cytochrome P450 3A Inhibitors [MoA]", "P-Glycoprotein Inhibitors [MoA]", "Cytochrome P450 2D6 Inhibitors [MoA]", "Organic Anion Transporting Polypeptide 1B1 Inhibitors [MoA]", "Organic Anion Transporting Polypeptide 1B3 Inhibitors [MoA]", "Breast Cancer Resistance Protein Inhibitors [MoA]", "Multidrug and Toxin Extrusion Transporter 1 Inhibitors [MoA]", "Nucleoside Reverse Transcriptase Inhibitors [MoA]" ], "pharm_class_epc": [ "Human Immunodeficiency Virus Integrase Strand Transfer Inhibitor [EPC]", "Cytochrome P450 3A Inhibitor [EPC]", "Human Immunodeficiency Virus Nucleoside Analog Reverse Transcriptase Inhibitor [EPC]" ], "pharm_class_cs": [ "Nucleosides [CS]" ], "unii": [ "4GDQ854U53", "LW2E03M5PG", "G70B4ETF4S", "FWF6Q91TZO" ] } } ] } } ] }